233 related articles for article (PubMed ID: 25324545)
1. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.
Bielecka E; Scavenius C; Kantyka T; Jusko M; Mizgalska D; Szmigielski B; Potempa B; Enghild JJ; Prossnitz ER; Blom AM; Potempa J
J Biol Chem; 2014 Nov; 289(47):32481-7. PubMed ID: 25324545
[TBL] [Abstract][Full Text] [Related]
2. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
3. A Secreted Bacterial Peptidylarginine Deiminase Can Neutralize Human Innate Immune Defenses.
Stobernack T; du Teil Espina M; Mulder LM; Palma Medina LM; Piebenga DR; Gabarrini G; Zhao X; Janssen KMJ; Hulzebos J; Brouwer E; Sura T; Becher D; van Winkelhoff AJ; Götz F; Otto A; Westra J; van Dijl JM
mBio; 2018 Oct; 9(5):. PubMed ID: 30377277
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
[TBL] [Abstract][Full Text] [Related]
5. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage.
Pyrc K; Milewska A; Kantyka T; Sroka A; Maresz K; Kozieł J; Nguyen KA; Enghild JJ; Knudsen AD; Potempa J
Infect Immun; 2013 Jan; 81(1):55-64. PubMed ID: 23090954
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.
Gawron K; Bereta G; Nowakowska Z; Lazarz-Bartyzel K; Lazarz M; Szmigielski B; Mizgalska D; Buda A; Koziel J; Oruba Z; Chomyszyn-Gajewska M; Potempa J
Mol Oral Microbiol; 2014 Dec; 29(6):321-32. PubMed ID: 25176110
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).
Maresz KJ; Hellvard A; Sroka A; Adamowicz K; Bielecka E; Koziel J; Gawron K; Mizgalska D; Marcinska KA; Benedyk M; Pyrc K; Quirke AM; Jonsson R; Alzabin S; Venables PJ; Nguyen KA; Mydel P; Potempa J
PLoS Pathog; 2013 Sep; 9(9):e1003627. PubMed ID: 24068934
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
[TBL] [Abstract][Full Text] [Related]
12. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
[TBL] [Abstract][Full Text] [Related]
13. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
Vitkov L; Hannig M; Minnich B; Herrmann M
Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
15. Dropping anchor: attachment of peptidylarginine deiminase via A-LPS to secreted outer membrane vesicles of Porphyromonas gingivalis.
Gabarrini G; Heida R; van Ieperen N; Curtis MA; van Winkelhoff AJ; van Dijl JM
Sci Rep; 2018 Jun; 8(1):8949. PubMed ID: 29895934
[TBL] [Abstract][Full Text] [Related]
16. Conserved Citrullinating Exoenzymes in Porphyromonas Species.
Gabarrini G; Chlebowicz MA; Vega Quiroz ME; Veloo ACM; Rossen JWA; Harmsen HJM; Laine ML; van Dijl JM; van Winkelhoff AJ
J Dent Res; 2018 May; 97(5):556-562. PubMed ID: 29298553
[TBL] [Abstract][Full Text] [Related]
17. Citrullination mediated by PPAD constrains biofilm formation in P. gingivalis strain 381.
Vermilyea DM; Ottenberg GK; Davey ME
NPJ Biofilms Microbiomes; 2019 Feb; 5(1):7. PubMed ID: 32029738
[TBL] [Abstract][Full Text] [Related]
18. There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis.
Gabarrini G; Palma Medina LM; Stobernack T; Prins RC; du Teil Espina M; Kuipers J; Chlebowicz MA; Rossen JWA; van Winkelhoff AJ; van Dijl JM
Virulence; 2018 Jan; 9(1):456-464. PubMed ID: 29505395
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new genetic variant (G231N, E232T, N235D) of peptidylarginine deiminase from
Bereta GP; Strzelec K; Łazarz-Bartyzel K; Dziedzic-Kowalska A; Nowakowska Z; Krutyhołowa A; Bielecka E; Kantyka T; Grabiec AM; Kaczmarzyk T; Chomyszyn-Gajewska M; Potempa J; Gawron K
Front Immunol; 2024; 15():1355357. PubMed ID: 38576615
[TBL] [Abstract][Full Text] [Related]
20.
Prucsi Z; Zimny A; Płonczyńska A; Zubrzycka N; Potempa J; Sochalska M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]